Corcept Therapeutics Incorporated (CORT)
$121.19+0.00%Close
BUYBULL · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $13.0B
- Beta
- 0.45
- P/E (TTM)
- 229.94
- Short % float
- 9.50%
- Days to cover
- 3.6
- SI change
- -8.7%
- 1W
- -0.69%
- 1M
- +7.45%
- vs SPY 1W
- -1.11%
- vs SPY 1M
- +5.39%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CORT?
- LOPJLB’s latest quantitative signal on Corcept Therapeutics Incorporated (CORT) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CORT in?
- Corcept Therapeutics Incorporated (CORT) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Corcept Therapeutics Incorporated (CORT) do?
- Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Kor…